Page last updated: 2024-10-26

diclofenac and Right Ventricular Dysfunction

diclofenac has been researched along with Right Ventricular Dysfunction in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jimenez, D1
Nieto, R1
Corres, J1
Fernández-Golfín, C1
Barrios, D1
Morillo, R1
Quezada, CA1
Huisman, M1
Yusen, RD1
Kline, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Diclofenac for Patients With Acute Submassive Pulmonary Embolism: a Randomized Clinical Trial[NCT01590342]Phase 2/Phase 334 participants (Actual)Interventional2012-05-31Terminated (stopped due to Low recruitment rate)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for diclofenac and Right Ventricular Dysfunction

ArticleYear
Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.
    Thrombosis research, 2018, Volume: 162

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Pilot Projects; Pul

2018